Appropriateness Criteria for Active Surveillance of Prostate Cancer-Reference-Cited by-同舟云学术

Appropriateness Criteria for Active Surveillance of Prostate Cancer

Published:2017-01 Issue:1 Volume:197 Page:67-74
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Cher Michael L.¹,Dhir Apoorv²,Auffenberg Gregory B.²,Linsell Susan²,Gao Yuqing²,Rosenberg Bradley³,Jafri S. Mohammad³,Klotz Laurence⁴,Miller David C.²,Ghani Khurshid R.²,Bernstein Steven J.⁵⁶,Montie James E.²,Lane Brian R.⁷,

Affiliation:

1. Department of Urology, Wayne State University, Detroit, Michigan

2. Department of Urology, University of Michigan, Ann Arbor, Michigan

3. Comprehensive Urology, Royal Oak, Michigan

4. Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

5. Department of Medicine, University of Michigan, Ann Arbor, Michigan

6. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan

7. Division of Urology, Spectrum Health, Grand Rapids, Michigan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference11 articles.

1. Trends in management for patients with localized prostate cancer, 1990-2013;Cooperberg;JAMA,2015

2. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer;Womble;Eur Urol,2015

3. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer;Filson;J Urol,2014

4. Physician variation in management of low-risk prostate cancer: a population-based cohort study;Hoffman;JAMA Intern Med,2014

5. The RAND/UCLA Appropriateness Method User’s Manual;Fitch,2001

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary Retention Evaluation and Catheterization Algorithm for Adult Inpatients;JAMA Network Open;2024-07-16

2. Integrative Care: Supporting Patients Through Complementary and Lifestyle Approaches;Transforming Prostate Cancer Care;2024

3. Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance;The Prostate;2023-05-12

4. Prostate Cancer Tumor Volume and Genomic Risk;European Urology Open Science;2023-02

5. Perspectives on the Role of Biopsy for Management of T1 Renal Masses: Survey Results From Two Regional Quality Improvement Collaboratives;Urology;2022-07